Aspirin, Doxylamine succinate, Phenylephrine bitartrate, and Dextromethorphan hydrobromide
Aspirin, Doxylamine succinate, Phenylephrine bitartrate, and Dextromethorphan hydrobromide · ASPIRIN 500 mg/1; DOXYLAMINE SUCCINATE 6.25 mg/1; PHENYLEPHRINE BITARTRATE 7.8 mg/1; DEXTROMETHORPHAN HYDROBROMIDE 10 mg/1 · Tablet, Effervescent · Bayer HealthCare LLC.
NDC 00280-1430-32 · 1600 POUCH in 1 CASE / 2 TABLET, EFFERVESCENT in 1 POUCH · DRUG FOR FURTHER PROCESSING · View full market →
Bulk ingredient — not a finished product
This NDC is a raw material (drug for further processing) sold to drug manufacturers or compounders, not a product pharmacies dispense. Retail pricing, TE codes, fragility scores, and shortage reports don't apply to bulk listings — those attach to finished products made from this ingredient.
Medicare Part D
This is a bulk ingredient, not a dispensable product — it is a raw material sold to manufacturers and compounders, so no plan prices it.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program · Opioid Analgesic REMS Shared System REMS
Regulatory
- Application
- —
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- —
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Aspirin, Doxylamine succinate, Phenylephrine bitartrate, and Dextromethorphan hydrobromide (Tablet, Effervescent)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Bayer HealthCare LLC. | ASPIRIN 500 mg/1; DOXYLAMINE SUCCINATE 6.25 mg/1; PHENYLEPHRINE BITARTRATE 7.8 mg/1; DEXTROMETHORPHAN HYDROBROMIDE 10 mg/1 | Aug 20, 2026 | Sep 3, 2026 |
| Bayer HealthCare LLC. | ASPIRIN 500 mg/1; DOXYLAMINE SUCCINATE 10 mg/1; PHENYLEPHRINE BITARTRATE 6.25 mg/1; DEXTROMETHORPHAN HYDROBROMIDE 7.8 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Bayer HealthCare LLC. | ASPIRIN 500 mg/1; DEXTROMETHORPHAN HYDROBROMIDE 10 mg/1; DOXYLAMINE SUCCINATE 6.25 mg/1; PHENYLEPHRINE BITARTRATE 7.8 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Aspirin, Doxylamine succinate, Phenylephrine bitartrate, and Dextromethorphan hydrobromide — NDC 00280-1430-32," retrieved September 3, 2026, https://drugdashboards.com/drug/00280143032.
Free to cite with attribution — see how the data is put together.